2016
DOI: 10.1134/s0026893316030092
|View full text |Cite
|
Sign up to set email alerts
|

Immunoreactivity of chimeric proteins carrying poliovirus epitopes on the VP6 of rotavirus as a vector

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…VP6 nanotubes (VP6T) and nanospheres (VP6S), when expressed in vitro [12,[24][25][26][27] under different conditions [25,28]. The rVP6 is highly immunogenic [9,12,29], and it has also been used as a carrier or delivery platform for heterologous protein antigens and genetically fused epitope-based vaccines, with improved response to the foreign antigen [30][31][32][33][34]. VP6 is stable at different pH conditions, and when delivered orally it was targeted to intestinal cells, offering a promising new delivery platform to transport pharmaceutical compounds to gastrointestinal tract [35].…”
Section: Introductionmentioning
confidence: 99%
“…VP6 nanotubes (VP6T) and nanospheres (VP6S), when expressed in vitro [12,[24][25][26][27] under different conditions [25,28]. The rVP6 is highly immunogenic [9,12,29], and it has also been used as a carrier or delivery platform for heterologous protein antigens and genetically fused epitope-based vaccines, with improved response to the foreign antigen [30][31][32][33][34]. VP6 is stable at different pH conditions, and when delivered orally it was targeted to intestinal cells, offering a promising new delivery platform to transport pharmaceutical compounds to gastrointestinal tract [35].…”
Section: Introductionmentioning
confidence: 99%